{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:50:21Z","timestamp":1782514221096,"version":"3.54.5"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["Grant No. OPPGH5299"],"award-info":[{"award-number":["Grant No. OPPGH5299"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>Serious bacterial neonatal infections are a major cause of global neonatal mortality. While hospitalized treatment is recommended, families cannot access inpatient treatment in low resource settings. Two parallel randomized control trials were conducted at five sites in three countries (Democratic Republic of Congo, Kenya, and Nigeria) to compare the effectiveness of treatment with experimental regimens requiring fewer injections with a reference regimen A (injection gentamicin plus injection procaine penicillin both once daily for 7 days) on the outpatient basis provided to young infants (0\u201359 days) with signs of possible serious bacterial infection (PSBI) when the referral was not feasible. Costs were estimated to quantify the financial implications of scaleup, and cost-effectiveness of these regimens.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Direct economic costs (including personnel, drugs and consumable costs) were estimated for identification, prenatal and postnatal visits, assessment, classification, treatment and follow-up. Data on time spent by providers on each activity was collected from 83% of providers. Indirect marginal financial costs were estimated for non-consumables\/capital, training, transport, communication, administration and supervision by considering only a share of the total research and health system costs considered important for the program. Total economic costs (direct plus indirect) per young infant treated were estimated based on 39% of young infants enrolled in the trial during 2012 and the number of days each treated during one year. The incremental cost-effectiveness ratio was calculated using treatment failure after one week as the outcome indicator. Experimental regimens were compared to the reference regimen and pairwise comparisons were also made.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>The average costs of treating a young infant with clinical severe infection (a sub-category of PSBI) in 2012 was lowest with regimen D (injection gentamicin once daily for 2 days plus oral amoxicillin twice daily for 7 days) at US$ 20.9 (95% CI US$ 16.4\u201325.3) or US$ 32.5 (2018 prices). While all experimental regimens B (injection gentamicin once daily plus oral amoxicillin twice daily, both for 7 days), regimen C (once daily of injection gentamicin injection plus injection procaine penicillin for 2 days, thereafter oral amoxicillin twice daily for 5 days) and regimen D were found to be more cost-effective as compared with the reference regimen A; pairwise comparison showed regimen D was more cost-effective than B or C. For fast breathing, the average cost of treatment with regimen E (oral amoxicillin twice daily for 7 days) at US$ 18.3 (95% CI US$ 13.4\u201323.3) or US$ 29.0 (2018 prices) was more cost-effective than regimen A. Indirect costs were 32% of the total treatment costs.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Scaling up of outpatient treatment for PSBI when the referral is not feasible with fewer injections and oral antibiotics is cost-effective for young infants and can lead to increased access to treatment resulting in potential reductions in neonatal mortality.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Clinical trial registration<\/jats:title>\n<jats:p>The trial was registered with Australian New Zealand Clinical\nTrials Registry under ID <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12610000286044\" xlink:type=\"simple\">ACTRN 12610000286044<\/jats:ext-link>.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0247977","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T17:24:48Z","timestamp":1615829088000},"page":"e0247977","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Costs and cost-effectiveness of management of possible serious bacterial infections in young infants in outpatient settings when referral to a hospital was not possible: Results from randomized trials in Africa"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7263-7647","authenticated-orcid":true,"given":"Charu C.","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"Tshefu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien Lokangaka","family":"Longombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Serge Ngaima","family":"Kila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Esamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gisore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adejumoke Idowu","family":"Ayede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adegoke Gbadegesin","family":"Falade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebunoluwa A.","family":"Adejuyigbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chineme Henry","family":"Anyabolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robinson D.","family":"Wammanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua Daba","family":"Hyellashelni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiyo","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Gram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir Bin","family":"Nisar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9688-9259","authenticated-orcid":true,"given":"Shamim Ahmad","family":"Qazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Bahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,3,15]]},"reference":[{"key":"pone.0247977.ref001","volume-title":"Estimates developed by the UN Interagency Group for Child Mortality Estimation","author":"UNICEF, WHO","year":"2019"},{"key":"pone.0247977.ref002","volume-title":"Estimates developed by the UN Interagency Group for Child Mortality Estimation","author":"UNICEF, WHO","year":"2018"},{"key":"pone.0247977.ref003","doi-asserted-by":"crossref","first-page":"e000347","DOI":"10.1136\/bmjgh-2017-000347","article-title":"Economic burden of neonatal sepsis in sub-Saharan Africa","volume":"3","author":"SL Ranjeva","year":"2018","journal-title":"BMJ Global Health"},{"issue":"8","key":"pone.0247977.ref004","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1473-3099(14)70804-7","article-title":"Estimates of possible severe bacterial infection in neonates in sub-Saharan Africa, South Asia, and Latin America for 2012: a systematic review and meta-analysis","volume":"14","author":"AC Seale","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"pone.0247977.ref005","volume-title":"Pocket book of hospital care for children: guidelines for the management of common childhood illnesses.","author":"WHO","year":"2013","edition":"2"},{"key":"pone.0247977.ref006","volume-title":"Management of the sick young infant aged up to 2 months Chart Booklet","author":"World Health Organization","year":"2019"},{"key":"pone.0247977.ref007","doi-asserted-by":"crossref","first-page":"e0231490","DOI":"10.1371\/journal.pone.0231490","article-title":"Caregiver acceptability of the guidelines for managing young infants with possible serious bacterial infections (PSBI) in primary care facilities in rural Bangladesh.","volume":"15","author":"JA Applegate","year":"2020","journal-title":"PLoS One"},{"key":"pone.0247977.ref008","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0140-6736(08)60835-1","article-title":"Effect of community-based newborn-care intervention package implemented through two service-delivery strategies in Sylhet district, Bangladesh: a cluster randomised controlled trial","volume":"371","author":"AH Baqui","year":"2008","journal-title":"Lancet"},{"key":"pone.0247977.ref009","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(08)61483-X","article-title":"Effect of community-based behaviour change management on neonatal mortality in Shivgarh, Uttar Pradesh, India: a cluster-randomised controlled trial","volume":"372","author":"V Kumar","year":"2008","journal-title":"Lancet"},{"key":"pone.0247977.ref010","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/INF.0b013e318256f86c","article-title":"Community-based treatment of serious bacterial infections in newborns and young infants: a randomized controlled trial assessing three antibiotic regimens","volume":"31","author":"AKM Zaidi","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"pone.0247977.ref011","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/jp.2010.191","article-title":"Why do families of sick newborns accept hospital care? A community-based cohort study in Karachi, Pakistan","volume":"31","author":"A Owais","year":"2011","journal-title":"J Perinatol"},{"key":"pone.0247977.ref012","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1186\/s12889-015-2330-0","article-title":"A systematic review of community-to-facility neonatal referral completion rates in Africa and Asia","volume":"15","author":"N Kozuki","year":"2015","journal-title":"BMC Public Health"},{"issue":"4","key":"pone.0247977.ref013","first-page":"126","article-title":"Non-use of formal health services in Malawi: perceptions from non-users","volume":"26","author":"AC Munthali","year":"2014","journal-title":"Malawi Med J"},{"key":"pone.0247977.ref014","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(14)62285-6","article-title":"Oral amoxicillin compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with fast breathing when referral is not possible: a randomised, open label, equivalence trial","volume":"385","author":"African Neonatal Sepsis Trial (AFRINEST) group","year":"2015","journal-title":"Lancet"},{"key":"pone.0247977.ref015","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(14)62284-4","article-title":"Simplified antibiotic regimens compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young Infants with clinical signs of severe infection when referral is not possible: a randomized equivalence trial","volume":"385","author":"African Neonatal Sepsis Trial (AFRINEST) group","year":"2015","journal-title":"Lancet"},{"key":"pone.0247977.ref016","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1016\/S2214-109X(14)70347-X","article-title":"Safety and efficacy of alternative antibiotic regimens compared with 7-day injectable procaine benzylpenicillin and gentamicin for outpatient treatment of neonates and young infants with clinical signs of severe infection when referral is not possible: a randomised open-label, equivalence trial","volume":"3","author":"A Baqui","year":"2015","journal-title":"Lancet Glob Heal"},{"key":"pone.0247977.ref017","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S2214-109X(16)30335-7","article-title":"Simplified antibiotic regimens for treatment of clinical severe infection in the outpatient setting when referral is not possible for young infants in Pakistan (Simplified Antibiotic Therapy Trial [SATT]): a randomised, open-label, equivalence trial","volume":"5","author":"F Mir","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"Suppl 1","key":"pone.0247977.ref018","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/INF.0b013e31829ff801","article-title":"Ensuring quality in AFRINEST and SATT: clinical standardization and monitoring","volume":"32","author":"SN Wall","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 1","key":"pone.0247977.ref019","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/INF.0b013e31829ff5fc","article-title":"Scientific rationale for study design of community-based simplified antibiotic therapy trials in newborns and young infants with clinically diagnosed severe infections or fast breathing in South Asia and sub-Saharan Africa","volume":"32","author":"AK Zaidi","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 1","key":"pone.0247977.ref020","first-page":"S26","article-title":"Simplified regimens for management of neonates and young infants with severe infection when hospital admission is not possible: study protocol for a randomized, open-label equivalence trial","volume":"32","author":"African Neonatal Sepsis Trial Group","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 1","key":"pone.0247977.ref021","first-page":"S33","article-title":"Treatment of fast breathing in neonates and young infants with oral amoxicillin compared with penicillin-gentamicin combination: study protocol for a randomized, open-label equivalence trial","volume":"32","author":"African Neonatal Sepsis Trial Group","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"pone.0247977.ref022","volume-title":"Guideline: Managing possible serious bacterial infection in young infants when referral is not feasible","author":"WHO","year":"2015"},{"issue":"1","key":"pone.0247977.ref023","doi-asserted-by":"crossref","first-page":"010408","DOI":"10.7189\/jogh.06.010408","article-title":"Cost of management of severe pneumonia in young children: systematic analysis","volume":"6","author":"S Zhang","year":"2016","journal-title":"J Glob Health"},{"key":"pone.0247977.ref024","doi-asserted-by":"crossref","first-page":"i21","DOI":"10.1093\/heapol\/czx054","article-title":"Community-Based Interventions for Newborns in Ethiopia (COMBINE): cost-effectiveness. analysis","volume":"32","author":"B Mathewos","year":"2017","journal-title":"Health Policy Plan"},{"key":"pone.0247977.ref025","doi-asserted-by":"crossref","first-page":"202","DOI":"10.9745\/GHSP-D-16-00312","article-title":"Effect on Neonatal Mortality of Newborn Infection Management at Health Posts When Referral Is Not Possible: A Cluster-Randomized Trial in Rural Ethiopia","volume":"5","author":"TD Hailegebriel","year":"2017","journal-title":"Glob Health Sci Pract"},{"issue":"2020","key":"pone.0247977.ref026","first-page":"107","article-title":"On discount rates for economic evaluations in global health","volume":"35","author":"M Haacker","journal-title":"Health Policy and Planning"},{"issue":"3","key":"pone.0247977.ref027","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7812\/TPP\/08-021","article-title":"A 36-hospital time and motion study: How do medical-surgical nurses spend their time?","volume":"12","author":"A Hendrich","year":"2008","journal-title":"PermJ"},{"key":"pone.0247977.ref028","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0140-6736(04)17021-9","article-title":"Effect of a participatory intervention with women\u2019s groups on birth outcomes in Nepal: cluster-randomised controlled trial","volume":"364","author":"DS Manandhar","year":"2004","journal-title":"Lancet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0247977","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T17:25:14Z","timestamp":1615829114000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0247977"}},"subtitle":[],"editor":[{"given":"Sandra A.","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,3,15]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0247977","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,15]]}}}